日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age

按年龄分层评估奥扎尼莫德治疗中重度活动性溃疡性结肠炎患者的安全性和有效性

Faye, Adam S; Rubin, David T; Siegel, Corey A; Long, Millie D; Khan, Nabeel; Danese, Silvio; Irving, Peter M; Cross, Raymond K; Blumenstein, Irina; Armuzzi, Alessandro; Horst, Sara N; Dignass, Axel; Kobayashi, Taku; Lawlor, Garrett; Krakovich, Anthony; Petersen, AnnKatrin; Liu, Zhaohui; Wang, Dong; Jain, Anjali; Ananthakrishnan, Ashwin N; Sabino, João

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease

关于炎症性肠病临床试验中皮质类固醇合理使用的国际共识

Hanžel, Jurij; Solitano, Virginia; Vuyyuru, Sudheer Kumar; Panaccione, Remo; Sands, Bruce E; Peyrin-Biroulet, Laurent; Danese, Silvio; D'Haens, Geert R; Atreya, Raja; Allez, Matthieu; Bernstein, Charles N; Bossuyt, Peter; Bressler, Brian; Bryant, Robert V; Cohen, Benjamin L; Colombel, Jean-Frederic; D'Amico, Ferdinando; Dignass, Axel; Dubinsky, Marla; Fleshner, Phillip; Gearry, Richard B; Hanauer, Stephen B; Hart, Ailsa L; Kayal, Maia; Kucharzik, Torsten; Lakatos, Peter L; Louis, Edouard; Magro, Fernando; Narula, Neeraj; Leong, Rupert W; Panés, Julián; Raine, Tim; Ran, Zhihua; Regueiro, Miguel D; Reinisch, Walter; Singh, Siddharth; Steinhart, A Hillary; Travis, Simon; Ungaro, Ryan C; van der Woude, C Janneke; Yamamoto, Takayuki; Ahuja, Vineet; Rubin, David T; Dulai, Parambir S; Cornfield, Linda J; Hogan, Malcolm; Sandborn, William J; Feagan, Brian G; Jairath, Vipul; Ma, Christopher

Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review

FDA和EMA关于溃疡性结肠炎药物研发指南的比较:专家组评论

Vieujean, Sophie; Sands, Bruce E; Panaccione, Remo; Rubin, David T; Jairath, Vipul; Danese, Silvio; Peyrin-Biroulet, Laurent; Schreiber, Stefan; Vermeire, Séverine; D'Haens, Geert; Dignass, Axel; Dulai, Parambir S; Narula, Neeraj; Reinisch, Walter

Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials

诱导治疗后达到内镜下缓解可减轻克罗恩病患者的住院负担:Risankizumab 和 Upadacitinib III 期试验的汇总事后分析结果

Panaccione, Remo; Ma, Christopher; Jairath, Vipul; Dignass, Axel; Joshi, Namita; Clark, Ryan; Griffith, Jenny; Kligys, Kristina; Semwal, Monika; Smith, Zachary; Mitchell, Dominic; Nunag, Dominic; Ferrante, Marc

Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial

既往生物制剂暴露对奥扎尼莫德在3期True North临床试验中的疗效和安全性的影响

Sands, Bruce E; Rubin, David T; Loftus, Edward V Jr; Wolf, Douglas C; Panaccione, Remo; Colombel, Jean-Frederic; Dignass, Axel; Regueiro, Miguel; Vermeire, Severine; Afzali, Anita; Lawlor, Garrett; Ahmad, Harris A; Wu, Hsiuanlin; Osterman, Mark T; Jain, Anjali; D'Haens, Geert

Inadequate Therapy Response on Advanced Therapy in Ulcerative Colitis Adult Patients: A Retrospective Analysis of German Health Claims Data

溃疡性结肠炎成人患者接受高级治疗后疗效不佳:德国医疗保险索赔数据的回顾性分析

Dignass, Axel; Blumenstein, Irina; Schwedhelm, Carolina; Strassen, Katrin; Kunk, Leonie; Marquardt, Sophie; Seiffert, Anna; Kulchytska, Nataliia; Hänsel, Ivonne; Benson, Alexa; Kisser, Agnes

Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study

炎症性肠病日常临床实践中的疾病监测及其对治疗决策的影响:来自炎症性肠病-PODCAST研究的真实世界证据

Dignass, Axel; Magro, Fernando; D'Amico, Ferdinando; Bamias, Giorgos; Caprioli, Flavio Andrea; Franchimont, Denis; Hart, Ailsa; Koch, Robert; Koutroubakis, Ioannis; Siffledeen, Jesse; Toruner, Murat; Leitner, Claudia; Heatta-Speicher, Tobias; Michelena, Naiara; Tornatore, Valentina; Gemignani, Lorenzo; Lapthorn, Jennifer; Kauffman, Laura; Gomollón, Fernando

Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease

克罗恩病黏膜和全层愈合及长期预后

Sands, Bruce E; Danese, Silvio; Chapman, J Casey; Gurjar, Khushboo; Grieve, Stacy; Thakur, Deepika; Griffith, Jenny; Joshi, Namita; Kligys, Kristina; Dignass, Axel

Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study

Mirikizumab 治疗溃疡性结肠炎 152 周连续治疗三年后的疗效和安全性:LUCENT-3 开放标签扩展研究的结果

Sands, Bruce E; D'Haens, Geert; Clemow, David B; Irving, Peter M; Johns, Jordan T; Gibble, Theresa Hunter; Abreu, Maria T; Lee, Scott D; Hisamatsu, Tadakazu; Kobayashi, Taku; Dubinsky, Marla C; Vermeire, Severine; Siegel, Corey A; Peyrin-Biroulet, Laurent; Moses, Richard E; Milata, Joe; Panaccione, Remo; Dignass, Axel

One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn's Disease: A Network Meta-Analysis

古塞库单抗与先进疗法治疗中重度活动性克罗恩病一年疗效比较:一项网络荟萃分析

Disher, Tim; Naessens, Dominik; Sanon, Myrlene; Bonner, Ashley; Ellis, Jenna; Bartlett, Meaghan; Hooper, Becky; Yang, Zijiang; Allegretti, Jessica R; Dignass, Axel